Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation.
about
Preventing stem cell transplantation-associated viral infections using T-cell therapyAntiviral T-cell therapyNucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host.Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.Human herpesviruses 6, 7, and 8 from a dermatologic perspective.Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?Optimisation of a quantitative polymerase chain reaction-based strategy for the detection and quantification of human herpesvirus 6 DNA in patients undergoing allogeneic haematopoietic stem cell transplantation.Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantationChallenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation.HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis.Sizing up the key determinants of the CD8(+) T cell response.Transmission of chromosomally integrated human herpesvirus 6 via cord blood transplantation.Peri-engraftment syndrome in allogeneic hematopoietic SCT.First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis.Identification of novel CD8+ T cell epitopes in human herpesvirus 6B U11 and U90.Human herpesvirus 6B immediate-early I protein contains functional HLA-A*02, HLA-A*03, and HLA-B*07 class I restricted CD8(+) T-cell epitopes.Impaired pulmonary immunity post-bone marrow transplant.Engraftment of donor cells with germ-line integration of HHV6 mimics HHV6 reactivation following cord blood/haplo transplantation.Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT.Severe pruritus and hypothermia as the primary manifestations of human herpes virus-6 encephalitis after pediatric cord blood transplantation.Human herpesvirus 6 in biopsies from patients with gastrointestinal symptoms after allogeneic stem cell transplantation.Human herpesvirus-6 pneumonitis in a patient with follicular lymphoma following immunochemotherapy with rituximab.
P2860
Q26801365-555D1641-842E-42EF-93D0-A297E463AB38Q27028006-04ADA17F-691E-4335-A0F9-294859EC53B6Q33713932-1ABF4BC3-5F20-4197-B761-52B7E99C9475Q33897804-892D8E34-AB83-422B-8BBF-60EE1889B472Q34273968-57699F19-0605-4ACA-A26A-5AF82F0CF82EQ34346918-AC0AB878-4EE8-4A71-BA31-28A73B6A5DAAQ35774717-B105BE55-CAA3-4EF0-836B-999898A52017Q35849274-3CF0748A-20D6-44F5-9061-EA50D32BF66CQ37006823-69867A4E-CDF1-4C16-AB07-76C7AD01652BQ37687412-EFBF985D-5B78-42E8-A28E-FB0921A37569Q38045704-A44BB26C-103C-40AD-BC83-D0B25E950F75Q38602553-54D45BE4-5E21-4A3D-8014-5E21BE32251FQ40079621-9CC1F6F8-75A9-4FE4-9720-1019BD83BAC8Q40273597-AECED59D-937B-4D73-91C2-29B690A78615Q40342657-247980E2-5521-4C52-B42E-D0F3E9AEF98FQ40884483-70AB9578-CEDD-4CAF-B1BA-04F1D59D2A1AQ41730520-15EE421A-9697-48E4-AF5A-6933DCA90EA2Q42572908-227B22C2-0DEB-4FD2-9F80-37539A254DD6Q42791756-5D817365-FFC6-4F08-AA6C-98A657EF39BEQ45350735-73463514-9A75-4AF8-90DD-58F4B16B92CBQ45368700-DBBF85FA-5861-4D39-9787-C0D1C4017C7BQ54341110-E7B4B415-B75E-4777-BFC9-AFCD5C68139AQ54947024-A8C6CD1F-C017-4829-B035-EAB45FB878B3
P2860
Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation.
@en
Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation.
@nl
type
label
Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation.
@en
Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation.
@nl
prefLabel
Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation.
@en
Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation.
@nl
P2093
P1476
Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation
@en
P2093
Debbie van Baarle
E A M Sanders
Ellen Meijer
P J de Pagter
Rob Schuurman
P304
P356
10.1016/J.JCV.2008.08.008
P577
2008-10-01T00:00:00Z